Open Access<p>Adenosine Inhibits Ovarian Cancer Growth Through Regulating RhoGDI2 Protein Expression</p>
Author(s) -
Bing Xia,
Jing Wang
Publication year - 2019
Publication title -
drug design, development and therapy
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.964
H-Index - 64
ISSN - 1177-8881
DOI - 10.2147/dddt.s219028
Subject(s) - angiogenesis , vascular endothelial growth factor , ovarian cancer , cancer research , cell growth , viability assay , cd31 , transfection , cell culture , biology , microbiology and biotechnology , chemistry , medicine , cancer , biochemistry , genetics , vegf receptors
This study aimed to investigate the effect of adenosine (Ado) on the growth of ovarian cancer and to explore the related mechanisms.